Background illustration for clinical trials search

Paid Clinical Trials Dallas

Discover 1,917 paid clinical trials in Dallas, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

for
Endometrial Cancer, Recurrent or Progressive Endometrial Cancer
Location: Dallas TX, Arlington TX, Bedford TX, Fort Worth TX,
Sponsor: Genmab

Sex: Female

Age: 18+

Code: NCT07166094

Phase3, Recruiting

Chemotherapy + Anakinra in Patients With Pancreatic Adenocarcinoma (PDAC)

for
Pancreatic Adenocarcinoma
Location: Dallas TX
Sponsor: Baylor Research Institute

Sex: All

Age: 18+

Code: NCT04926467

Phase2, Recruiting

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

for
Pancreatic Cancer, PDAC,
Location: Dallas TX, Longview TX, Lawrence KS, Kansas City MO,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT07252232

Phase3, Recruiting

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

for
Ovarian Neoplasms, Breast Neoplasms,
Location: Dallas TX, St Louis MO, Indianapolis IN, Madison WI,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07213791

Phase1, Recruiting

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

for
Non-Small-Cell Lung Cancer,
Location: Dallas TX, Houston TX, Aurora CO, Arlington Heights IL,
Sponsor: ArriVent BioPharma, Inc.

Sex: All

Age: 18+

Code: NCT07185997

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

for
HER2-positive Breast Cancer, Breast Cancer
Location: Dallas TX, Shreveport LA, Houston TX, San Antonio TX,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07102381

Phase2, Recruiting

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

for
High Risk Cardiovascular Disease, Hypertension,
Location: Dallas TX, Duncanville TX, Mesquite TX, Carrollton TX,
Sponsor: Alnylam Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07181109

Phase3, Recruiting

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

for
Colon Adenocarcinoma, Rectal Adenocarcinoma
Location: Dallas TX, Denison TX, San Antonio TX, Hattiesburg MS,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06997497

Phase3, Recruiting

TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

for
Transthyretin Amyloidosis With Cardiomyopathy
Location: Dallas TX, Plano TX, Austin TX, Houston TX,
Sponsor: Alnylam Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT07052903

Phase3, Recruiting

Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)

for
Lung Neoplasm
Location: Dallas TX, Lexington KY, Fairfax VA, Baltimore MD
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06780098

Phase2, Recruiting

A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Dallas TX, Tyler TX, San Antonio TX, Baton Rouge LA,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06943872

Phase3, Recruiting

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

for
Breast Neoplasms, Triple Negative Breast Neoplasms,
Location: Dallas TX, Flower Mound TX, Fort Worth TX, Abilene TX,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06966700

Phase3, Recruiting

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

for
Pancreatic Neuroendocrine Tumor (pNET),
Location: Dallas TX, Metairie LA, St Louis MO, Birmingham AL,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT06943755

Phase2, Phase3, Recruiting

A Study of ZL-1310 in Participants With Selected Solid Tumors

for
Solid Tumors
Location: Dallas TX, Houston TX, McAllen TX, Nashville TN,
Sponsor: Zai Lab (Shanghai) Co., Ltd.

Sex: All

Age: 18+

Code: NCT06885281

Phase1, Phase2, Recruiting

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

for
Breast Neoplasms
Location: Dallas TX, Fort Worth TX, Houston TX, San Antonio TX,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07060807

Phase3, Recruiting

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

for
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic,
Location: Dallas TX, Irving TX, Plano TX, Arlington TX,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07144280

Phase3, Recruiting

A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer

for
Small Cell Lung Cancer
Location: Dallas TX, Daphne AL, Grand Island NE, Nashville TN,
Sponsor: Puma Biotechnology, Inc.

Sex: All

Age: 18+

Code: NCT06095505

Phase2, Recruiting

Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic Malignancies

for
Endometrioid Endometrial Cancer
Location: Dallas TX, Fort Worth TX, Tucson AZ, Greenville SC,
Sponsor: Traws Pharma, Inc.

Sex: Female

Age: 18+

Code: NCT05705505

Phase1, Phase2, Recruiting

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

for
Renal Cell Carcinoma
Location: Dallas TX, Lubbock TX, St Louis MO, Nashville TN,
Sponsor: HiberCell, Inc.

Sex: All

Age: 18+

Code: NCT06234605

Phase1, Recruiting

Cardiogenic Shock Working Group Registry

for
Cardiogenic Shock
Location: Dallas TX, Houston TX, Galveston TX, Chicago IL,
Sponsor: Tufts Medical Center

Sex: All

Age: 18+

Code: NCT04682483

Recruiting

Dallas is a key hub for clinical trials, largely thanks to its extensive healthcare network and premier research institutions. Renowned centers such as UT Southwestern Medical Center, Baylor University Medical Center, and the Texas Health Presbyterian Hospital are at the forefront of clinical research, leading studies across various medical fields.

These institutions are known for their innovative approaches and commitment to advancing medical science, making Dallas, Texas a prominent location for cutting-edge clinical trials and new treatment developments.

Why choose Dallas for clinical trials?

Dallas offers distinct advantages for those considering participation in clinical trials. The city's growing health sciences industry and diverse population provides a wide range of participants, which improves the accuracy and applicability of research findings. Dallas is also renowned for its innovative research landscape, with a strong emphasis on medical advancements and groundbreaking studies.

Common conditions studied in Dallas

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Dallas